For circulating angiogenic growth factors levels, compared to nondiabetes participants, diabetes patients had higher levels of plasma Ang-2 and VEGF and lower levels of Ang-1 (Table 1). This evidence concerns the gene ANGPT2 and diabetes mellitus.